MIT-Engineered Peptide Targets COVID-19 |
|
|
|
Using computational models of protein interactions, researchers at the Massachusetts Institute of Technology Media Lab and Center for Bits and Atoms have designed a peptide that binds to coronavirus proteins and shuttles them into a cellular pathway that breaks them down. The researchers say this peptide has potential as a treatment that would prevent the SARS-CoV-2 virus from reproducing itself within infected cells.
|
|
|
|
|
|
|
|
|
Redefinition and Harmonization in Biotech Regulation Necessary, Experts Say |
|
|
|
Several regulatory frameworks are no longer applicable, thus there's a need to redefine regulatory approach for biotechnology to maximize its potential and benefits. This is according to Dr. Markus Wyss, Strain Director of DSM Switzerland's Global Regulatory Affairs and Quality Management and one of the speakers in the ISAAA Webinar Genome Editing 101: Healthcare and Industrial Applications and Regulations held via Zoom on June 19, 2020.
|
|
|
|
|
|
|

|
A biweekly update on gene editing research, regulations, and impact
produced by ISAAA Inc. |
| |
|
|

|
| A monthly update on gene drive research and development provided by ISAAA in collaboration with the Outreach Network for Gene Drive Research |
| |
|
|
|
|
|
|